Veriq is a specialist MedTech evidence-generation partner, helping innovators, manufacturers and investors generate the clinical evidence required for regulatory approval, market access and adoption.
Our team combines clinical leadership, regulatory expertise and a research-active network of leading investigators and high-performing NHS and independent sector sites. We are designed specifically to accelerate MedTech studies, delivering rapid study start-up, efficient recruitment and high-quality data generation.
From early feasibility and first-in-human investigations through pivotal clinical studies and post-market follow-up, Veriq provides integrated support across the full product lifecycle. Our expertise spans study design, regulatory strategy, clinical operations, data management, health economics and evidence generation aligned with UKCA, EU MDR and FDA requirements.
By combining specialist MedTech knowledge, operational excellence and strong clinical engagement, we help sponsors reduce development risk, accelerate market access and bring innovative technologies to patients faster.
Veriq’s partnership model ensures prioritisation, quality, and speed – delivering studies significantly faster and at lower cost than comparable programmes in the US.
Full project delivery including contracting, site coordination, recruitment, and data management through our pre-primed UK network.
Guidance aligned with MHRA, MDR, and FDA requirements to ensure smooth approval pathways for UK, EU, and US markets.
Demonstrating cost-effectiveness and clinical value to support adoption into healthcare systems such as the NHS.
Long-term evidence generation to support real-world performance and compliance.
Get in touch to find out more about how we can help design and deliver clinical studies tailored for better outcomes, higher data quality, and faster execution.
Get in touch